Metalloporphyrins inactivate caspase-3 and -8

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Caspase activation is a key early event in apoptotic cell death.
• Heme oxygenase-1 (HO-1) is implicated in regulating apoptosis, with metalloporphyrins often used to modulate its activity.
• Current understanding lacks clarity on the direct effects of metalloporphyrins on caspases.

Purpose of the Study:

• To investigate the direct inhibitory effects of metalloporphyrins on caspase activity.
• To determine if metalloporphyrins can inhibit caspase-3 and caspase-8 in vitro and in vivo.
• To elucidate the mechanism by which metalloporphyrins interact with caspases.

Main Methods:

• Assessing caspase-3 and caspase-8 activity in Fas ligand-treated Jurkat T-lymphocytes and with recombinant caspases.
• Utilizing a mouse model of Fas-induced liver apoptosis.
• Performing molecular modeling studies to analyze porphyrin-caspase interactions.
• Analyzing caspase-3-mediated PARP cleavage.

Main Results:

• Metalloporphyrins (cobalt(III) protoporphyrin IX, tin and zinc(II) protoporphyrin-IX) inhibited caspase-3 and caspase-8 activity.
• This inhibition was observed in vitro and in vivo using a mouse model.
• Metalloporphyrins were shown to inhibit caspase-3-mediated PARP cleavage.
• Molecular modeling confirmed favorable binding of porphyrins to the caspase-3 active site.

Conclusions:

• Metalloporphyrins act as direct inhibitors of caspase-3 and caspase-8 activity.
• The findings highlight the need for careful use of metalloporphyrins when studying HO-1 and apoptosis.
• Metalloporphyrins' direct caspase inhibitory action may confound interpretations of HO-1 modulation studies.